Background review for cyclodextrins used as excipients

[1]  G. Würthwein,et al.  Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients. , 2012, The Journal of antimicrobial chemotherapy.

[2]  E. Ergenekon,et al.  Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates. , 2011, The Turkish journal of pediatrics.

[3]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins: basic science and product development , 2010, The Journal of pharmacy and pharmacology.

[4]  M. Mihatsch,et al.  Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  Rajeswari Challa,et al.  Cyclodextrins in drug delivery: An updated review , 2005, AAPS PharmSciTech.

[6]  P. Elsner,et al.  Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro. , 2007, Journal of biomedical materials research. Part A.

[7]  Thorsteinn Loftsson,et al.  Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.

[8]  R. Kauffman,et al.  Single-Dose Pharmacokinetics of Intravenous Itraconazole and Hydroxypropyl-β-Cyclodextrin in Infants, Children, and Adolescents , 2007, Antimicrobial Agents and Chemotherapy.

[9]  K. Welte,et al.  Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: A pilot study for evaluation of safety and efficacy , 2007, Pediatric transplantation.

[10]  F. Eifinger,et al.  Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight , 2006, Journal of Perinatology.

[11]  S. Gould,et al.  2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review , 2005 .

[12]  R. Jacobs,et al.  Intravenous Voriconazole Therapy in a Preterm Infant , 2005, Pharmacotherapy.

[13]  S. Gould,et al.  2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  P. Newberne,et al.  Safety assessment of ?-cyclodextrin , 2004 .

[15]  M. Morishita,et al.  The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. , 2002, International journal of pharmaceutics.

[16]  E. Stefánsson,et al.  Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. , 2002, Acta ophthalmologica Scandinavica.

[17]  M. Másson,et al.  Cyclodextrins in topical drug formulations: theory and practice. , 2001, International journal of pharmaceutics.

[18]  K. H. Langer,et al.  Subchronic Intravenous Toxicity Studies with γ-Cyclodextrin in Rats , 1998 .

[19]  S. Keipert,et al.  Influence of alpha-cyclodextrin and hydroxyalkylated beta-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions. , 1997, Journal of pharmaceutical sciences.

[20]  K. Uekama,et al.  Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. , 1997, Journal of pharmaceutical sciences.

[21]  T. G. Smith,et al.  β-Cyclodextrin : 52-week toxicity studies in the rat and dog , 1995 .

[22]  T. Kondo,et al.  Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository. , 1992, Journal of pharmaceutical sciences.

[23]  D. Frank,et al.  Cyclodextrin nephrosis in the rat. , 1976, The American journal of pathology.